SAN MATEO, CA, Mendaera, a healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding.
Mendaera, healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera’s efforts to scale robotics and AI across mainstream medical procedures.
Mendaera’s vision is to digitize clinical judgment and technical expertise, making high-quality care available for every patient at every care facility. Its platform in development combines robotics, AI, real-time imaging, and connectivity, to enable intervention at scale. Mendaera’s robotic system has not been cleared by the FDA for sale in the United States.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
By VC News Daily
Source: VC News Daily